Pricing Log in Create free account

Indaptus Therapeutics, Inc. (INDP) vs MapLight Therapeutics, Inc. (MPLT)

Indaptus Therapeutics, Inc. and MapLight Therapeutics, Inc. are both Biotechnology companies. Indaptus Therapeutics, Inc. and MapLight Therapeutics, Inc. are of similar size ($445.7M and $437.7M). Across the 9 metrics below, Indaptus Therapeutics, Inc. leads on 5 and MapLight Therapeutics, Inc. on 4.

Valuation

Metric INDP MPLT Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 26.86 1.00 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (240.51%) (549.48%) (33.15%)
Free cash flow yield (4.81%) (50.06%) (25.50%)

Profitability

Metric INDP MPLT Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (318.04%) (297.18%) (56.36%)
Return on assets (163.84%) (124.79%) (48.04%)
Return on invested capital 0.00% (348.44%) 0.00%

Growth

Metric INDP MPLT Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 52.15% 82.39% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric INDP MPLT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 19.48 16.52 4.72
Net debt to EBITDA 0.43 1.79 0.96

Dividend

Metric INDP MPLT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric INDP MPLT Biotechnology median
Market cap 437.70m 445.72m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack